Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Amyris Inc AMRS


Primary Symbol: AMRSQ

Chemicals Specialty Chemicals
Amyris, Inc. is a synthetic biotechnology company. The component of the Company is derived from marketing and selling Clean Beauty, Personal Care, and Health & Wellness consumer products through its direct-to-consumer e-commerce platforms and a growing network of retail partners. The Company’s sustainable ingredients are sold in bulk to industrial leaders who serve Flavor & Fragrance (F&F), Nutrition, Food & Beverage, and Clean Beauty & Personal Care end markets. The ingredients and consumer products it produces by its Lab-to-Market technology platform. The Company leverages machine learning, robotics, and artificial intelligence, which enables its technology platform to rapidly bring new market at commercial scale. The Lab-to-Market technology platform utilizes optimized and automated molecular biology, analytical, and process development tools combined with machine learning algorithms and statistical models to transform the way microbes metabolize sugars.


GREY:AMRSQ - Post by User

Amyris Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by TAswingon Oct 18, 2016 9:35am
176 Views
Post# 25355096

RE:Just got in at 0.795, it seems like it's going back to $1

RE:Just got in at 0.795, it seems like it's going back to $1As I said, $1 coming, maybe even today!! Kind of funny to see nobody on this BB with such an opportunity but I guess like me most people are Canadian investors and usually trading TSXV stocks.

I'll be honest this is the 2nd time ever that I trade US stocks and I love it! The volume is huge, the potential for trading is so much better than any stocks on the venture and the gain is 30% higher right now with the exchange rate. Lovin it...


TAswing wrote: Momentum is in and even though overbought for a while, it's still up on high volume and just got over the 200 moving average of about 0.82 again. That and a buy + strong buy and the fact they need to get back over a dollar by year's end to stay on NASDAQ. I also like the last news release. I just wish I had more cash flow available to buy more.


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities